Memorial Sloan Kettering Cancer Center Y M Abs Therapeutics, Inc. Transaction History
Memorial Sloan Kettering Cancer Center
- $24.6 Million
- Q3 2023
A detailed history of Memorial Sloan Kettering Cancer Center transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Memorial Sloan Kettering Cancer Center holds 191,176 shares of YMAB stock, worth $1.65 Million. This represents 4.24% of its overall portfolio holdings.
Number of Shares
191,176
Previous 191,176
-0.0%
Holding current value
$1.65 Million
Previous $1.3 Million
19.8%
% of portfolio
4.24%
Previous 4.1%
Shares
2 transactions
Others Institutions Holding YMAB
# of Institutions
33Shares Held
14.4MCall Options Held
24KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY3.42MShares$29.4 Million10.09% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$25.3 Million0.0% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ143KShares$1.23 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL112KShares$968,4780.0% of portfolio
-
Ziegler Capital Management, LLC35.5KShares$305,3190.02% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $376M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...